Atl1102 is doing a trial with non ambulant boys in DMD in combination with steroids
Heres the interesting thing !
After the 12 month trial and Atl1102 is safe and tolerable and past 6 month futility showing signs of efficacy..
Then the
Physicians, could choose to use the drug in combination ahead of an approval (off-label as noted above) a decision that will be based on their view of the likely efficacy and safety of the combination.
Im talking about INFLAMMATION (Atl1102 )
So : Atl 1102 could be used to reduce inflammation ( Corticosteroods will get the flick imo)
Conclusion
In 12 months Atl1102 could be earning an income re anti inflammation in Europe and the US….imo
Chart, page-5612
Add PER (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
7.0¢ |
Change
-0.002(2.78%) |
Mkt cap ! $64.91M | |||
| Open | High | Low | Value | Volume |
| 7.2¢ | 7.3¢ | 7.0¢ | $77.28K | 1.090M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 20045 | 7.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 7.1¢ | 75177 | 1 |
View Market Depth
| Last trade - 14.57pm 30/04/2024 (20 minute delay) ? |
|
|||||
|
Last
7.0¢ |
Change
-0.002 ( 1.41 %) |
||||
| Open | High | Low | Volume | ||
| 7.2¢ | 7.3¢ | 7.0¢ | 91740 | ||
| Last updated 14.57pm 30/04/2024 ? | |||||
| PER (ASX) Chart |